Dr. Datson enters into contract manufacturing partnership with Ochoa Labs

12 Mar 2015 Evaluate

Dr. Datson has entered into an exclusive contract manufacturing partnership with Ochoa Labs. Dr. Datsons Labs will manufacture on an exclusive basis to the Ochoa Labs requirements of Docetaxel Anhydrous, Irinotecan Hydrochloride, Topotecan Hydrochloride, Semi Synthetic Paclitaxel, Gemcltablne Hydrochloride, Capecitabine, Imatinib Mesylate Gefitinib in finished formulations.

Recently, the company received the proposal to supply the Artemisinin-based combination therapies (ACTs) to the Clinton Health Access Initiative (CHAI), the healthcare project of the Clinton Foundation.

Dr. Datsons Labs is a leading research based integrated pharmaceutical company with established research, manufacturing and marketing capabilities. It is R&D focused, has a multi product portfolio with state of the art manufacturing facilities, and is set to become a marketing conglomerate across the globe.

 

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×